Drug interactions
Elacestrant + Netupitant-palonosetron
Severity: Moderate
Elacestrant and Netupitant-palonosetron: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Netupitant, a moderate CYP3A4 inhibitor, can increase elacestrant exposure. Higher levels may increase adverse effects such as nausea, dyslipidemia and musculoskeletal pain.
What this interaction means in plain words
Elacestrant and Netupitant-palonosetron can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Elacestrant belongs to Oncology; Netupitant-palonosetron belongs to Gastrointestinal Tract.
Why it happens
CYP3A4 inhibition by netupitant reduces elacestrant metabolism.
What to do
Avoid combining where possible, using an alternative antiemetic. If used, monitor for elacestrant adverse effects and lipid levels.
What to ask your pharmacist
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Elacestrant and Netupitant-palonosetron, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 14 days on the web. No card needed.
Other interactions of Netupitant-palonosetron
- Apomorphine + Netupitant-palonosetron Contraindicated
- Flibanserin + Netupitant-palonosetron Contraindicated
- Apalutamide + Netupitant-palonosetron Major
- Avapritinib + Netupitant-palonosetron Major
- Carbamazepine + Netupitant-palonosetron Major
- Cobimetinib + Netupitant-palonosetron Major
Other interactions of Elacestrant
Frequently asked questions
Can I take Elacestrant with Netupitant-palonosetron?
MediHelp rates the interaction as moderate. Elacestrant and Netupitant-palonosetron can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Netupitant, a moderate CYP3A4 inhibitor, can increase elacestrant exposure. Higher levels may increase adverse effects such as nausea, dyslipidemia and musculoskeletal pain.
How serious is the interaction between Elacestrant and Netupitant-palonosetron?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid combining where possible, using an alternative antiemetic. If used, monitor for elacestrant adverse effects and lipid levels.
What other medicines interact with Netupitant-palonosetron?
MediHelp also lists interactions of Netupitant-palonosetron with, for example, Apomorphine, Flibanserin, Apalutamide. The full list is on the Netupitant-palonosetron page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
